NO890833L - Fremstilling av kallikrein. - Google Patents
Fremstilling av kallikrein.Info
- Publication number
- NO890833L NO890833L NO89890833A NO890833A NO890833L NO 890833 L NO890833 L NO 890833L NO 89890833 A NO89890833 A NO 89890833A NO 890833 A NO890833 A NO 890833A NO 890833 L NO890833 L NO 890833L
- Authority
- NO
- Norway
- Prior art keywords
- callique
- preparation
- kallikrein
- kallikreins
- procaryotic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6859487A | 1987-06-30 | 1987-06-30 | |
US21025688A | 1988-06-27 | 1988-06-27 | |
PCT/US1988/002214 WO1989000192A1 (en) | 1987-06-30 | 1988-06-29 | Production of kallikrein |
Publications (2)
Publication Number | Publication Date |
---|---|
NO890833D0 NO890833D0 (no) | 1989-02-27 |
NO890833L true NO890833L (no) | 1989-04-27 |
Family
ID=26749136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89890833A NO890833L (no) | 1987-06-30 | 1989-02-27 | Fremstilling av kallikrein. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0297913B1 (pt) |
JP (1) | JPH01503679A (pt) |
KR (1) | KR890701731A (pt) |
AT (1) | ATE118547T1 (pt) |
AU (1) | AU627427B2 (pt) |
DE (1) | DE3853023T2 (pt) |
DK (1) | DK91389A (pt) |
ES (1) | ES2068201T3 (pt) |
FI (1) | FI890889A (pt) |
GR (1) | GR3015881T3 (pt) |
NO (1) | NO890833L (pt) |
NZ (1) | NZ225230A (pt) |
PT (1) | PT87887B (pt) |
WO (1) | WO1989000192A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4036392A1 (de) * | 1990-11-15 | 1992-05-21 | Behr Gmbh & Co | Latentwaermespeicher |
US6103237A (en) * | 1993-07-22 | 2000-08-15 | Hybritech Incorporated | Stable variant hK2 polypeptide |
US5516639A (en) * | 1993-07-22 | 1996-05-14 | Mayo Foundation For Medical Education And Research | Antibodies specific for human prostate glandular kallkrein |
CA2189774A1 (en) * | 1994-05-10 | 1995-11-16 | Donald J. Tindall | Recombinant hk2 polypeptide |
US5955306A (en) * | 1996-09-17 | 1999-09-21 | Millenium Pharmaceuticals, Inc. | Genes encoding proteins that interact with the tub protein |
US6479263B1 (en) | 1996-11-14 | 2002-11-12 | Baylor College Of Medicine | Method for detection of micrometastatic prostate cancer |
US5840871A (en) * | 1997-01-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Prostate-associated kallikrein |
US5948616A (en) * | 1997-05-14 | 1999-09-07 | Musc Foundation For Research Development | Methods and compositions of correlating tissue kallikrein gene promoter polymorphisms with essential hypertension |
US6376182B1 (en) | 1997-05-14 | 2002-04-23 | Medical University Of South Carolina | Methods and compositions for correlating tissue kallikrein gene promoter polymorphisms with treatment of essential hypertension |
US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
WO1998059073A1 (en) | 1997-06-20 | 1998-12-30 | Mayo Foundation For Medical Education And Research | Method for detection of breast cancer |
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
JP2005532057A (ja) | 2002-07-09 | 2005-10-27 | バクスター・インターナショナル・インコーポレイテッド | 細胞を培養するための動物性タンパク質非含有培地 |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
CA2633306A1 (en) | 2006-01-04 | 2007-07-12 | Baxter International Inc. | Oligopeptide-free cell culture media |
WO2009039704A1 (fr) * | 2007-09-27 | 2009-04-02 | Shanghai Wanxing Biopharmaceuticals, Co., Ltd. | Procédé de fabrication de kallikréine 1 humaine |
WO2013173923A1 (en) * | 2012-05-25 | 2013-11-28 | Diamedica, Inc. | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
WO2013181755A1 (en) * | 2012-06-04 | 2013-12-12 | Diamedica Inc. | Human tissue kallikrein 1 glycosylation isoforms |
US11857608B2 (en) | 2017-03-09 | 2024-01-02 | Diamedica Inc. | Dosage forms of tissue kallikrein 1 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3905870A (en) * | 1972-11-03 | 1975-09-16 | Bayer Ag | Purification of kallikrein |
DE3103257A1 (de) * | 1981-01-31 | 1982-08-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung des hochreinen enzyms kallikrein aus schweinepankreas-extrakten |
JPS5838151B2 (ja) * | 1981-07-03 | 1983-08-20 | 衛 杉浦 | カリクレインの精製法 |
JPS596883A (ja) * | 1982-06-30 | 1984-01-13 | Nippon Chem Res Kk | 人尿カリクレインの濃縮精製法 |
JPS59102392A (ja) * | 1982-12-02 | 1984-06-13 | Nippon Chem Res Kk | 熱安定性を有するヒト尿キニノゲナーゼ水溶液の製造法 |
JPS6092220A (ja) * | 1983-10-26 | 1985-05-23 | Ss Pharmaceut Co Ltd | カリクレインの精製法 |
JPS6121086A (ja) * | 1984-07-10 | 1986-01-29 | Amano Pharmaceut Co Ltd | カリクレインおよびエラスタ−ゼの取得方法 |
WO1987002709A1 (en) * | 1985-10-24 | 1987-05-07 | Biotechnology Research Partners, Ltd. | Blood tests diagnostic for hypertension |
JPS62126980A (ja) * | 1985-11-26 | 1987-06-09 | Shigetada Nakanishi | Dna断片 |
-
1988
- 1988-06-29 KR KR1019890700390A patent/KR890701731A/ko not_active Application Discontinuation
- 1988-06-29 WO PCT/US1988/002214 patent/WO1989000192A1/en active Application Filing
- 1988-06-29 JP JP63506049A patent/JPH01503679A/ja active Pending
- 1988-06-29 AU AU20755/88A patent/AU627427B2/en not_active Ceased
- 1988-06-30 PT PT87887A patent/PT87887B/pt not_active IP Right Cessation
- 1988-06-30 ES ES88306039T patent/ES2068201T3/es not_active Expired - Lifetime
- 1988-06-30 DE DE3853023T patent/DE3853023T2/de not_active Expired - Fee Related
- 1988-06-30 EP EP88306039A patent/EP0297913B1/en not_active Expired - Lifetime
- 1988-06-30 NZ NZ225230A patent/NZ225230A/en unknown
- 1988-06-30 AT AT88306039T patent/ATE118547T1/de not_active IP Right Cessation
-
1989
- 1989-02-24 FI FI890889A patent/FI890889A/fi not_active IP Right Cessation
- 1989-02-27 DK DK091389A patent/DK91389A/da not_active Application Discontinuation
- 1989-02-27 NO NO89890833A patent/NO890833L/no unknown
-
1995
- 1995-04-19 GR GR950401018T patent/GR3015881T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT87887A (pt) | 1989-05-31 |
EP0297913A2 (en) | 1989-01-04 |
ATE118547T1 (de) | 1995-03-15 |
PT87887B (pt) | 1994-05-31 |
DE3853023D1 (de) | 1995-03-23 |
DK91389A (da) | 1989-05-01 |
FI890889A0 (fi) | 1989-02-24 |
AU2075588A (en) | 1989-01-30 |
FI890889A (fi) | 1989-02-24 |
DE3853023T2 (de) | 1995-06-08 |
EP0297913A3 (en) | 1990-03-07 |
KR890701731A (ko) | 1989-12-21 |
JPH01503679A (ja) | 1989-12-14 |
AU627427B2 (en) | 1992-08-27 |
DK91389D0 (da) | 1989-02-27 |
NO890833D0 (no) | 1989-02-27 |
ES2068201T3 (es) | 1995-04-16 |
NZ225230A (en) | 1991-06-25 |
GR3015881T3 (en) | 1995-07-31 |
WO1989000192A1 (en) | 1989-01-12 |
EP0297913B1 (en) | 1995-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO890833D0 (no) | Fremstilling av kallikrein. | |
NO871785L (no) | Fremgangsmaate for fremstilling av et proteinprodukt samt vektorsystem for fremgangsmaatens utfoerelse. | |
FI844597L (fi) | Foerfarande foer framstaellning av en synnerligen ren hyaluronsyra. | |
ATE248925T1 (de) | Verfahren zur herstellung von proteinen oder proteinhaltigen genprodukten | |
DE69033032D1 (de) | Integriertes zellkultur-proteinreinigungssystem zur automatisierten herstellung und reinigung von zellkulturprodukten | |
AU6733487A (en) | Mammalian interleukin-4 | |
IL88223A0 (en) | Polypeptides,process,nucleotide sequences,expression vectors and host organisms for their production and pharmaceutical compositions comprising them | |
PH25120A (en) | Replicable expression vehicle and process of preparation thereof | |
DE68923123D1 (de) | Herstellung von Proteinen. | |
NO891716D0 (no) | Ekspresjon av humant serumalbumin i metylotrofe gjaersorter | |
FI103987B1 (fi) | Interleukiini-7 | |
DE3683267D1 (de) | Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung. | |
FR2607517B2 (fr) | Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu | |
DE69432856D1 (de) | Zufuhr von genprodukten mittels mesangium-zellen |